The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Leishmaniasis: Current Status of Vaccine Development
Open accessAbstract
SUMMARY: Leishmaniae are obligatory intracellular protozoa in mononuclear phagocytes. They cause a spectrum of diseases, ranging in severity from spontaneously healing skin lesions to fatal visceral disease. Worldwide, there are 2 million new cases each year and 1/10 of the world's population is at risk of infection. To date, there are no vaccines against leishmaniasis and control measures rely on chemotherapy to alleviate disease and on vector control to reduce transmission. However, a major vaccine development program aimed initially at cutaneous leishmaniasis is under way. Studies in animal models and humans are evaluating the potential of genetically modified live attenuated vaccines, as well as a variety of recombinant antigens or the DNA encoding them. The program also focuses on new adjuvants, including cytokines, and delivery systems to target the T helper type 1 immune responses required for the elimination of this intracellular organism. The availability, in the near future, of the DNA sequences of the human and Leishmania genomes will extend the vaccine program. New vaccine candidates such as parasite virulence factors will be identified. Host susceptibility genes will be mapped to allow the vaccine to be targeted to the population most in need of protection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene
Fleming, M. D., Trenor, C. C., Su, M. A., Foernzler, D., Beier, D. R., Dietrich, W. F., & Andrews, N. C. (1997) · Nature Genetics · doi:10.1038/ng0897-383 · Cited by 1,159 · cited 1×
“The precise biological function of NRAMP1 is not yet known, but a closely related protein, NRAMP2, is a transporter of iron from endosomes to the cytoplasm (41).”
BackgroundDonnelly, J. J., Ulmer, J. B., Shiver, J. W., & Liu, M. A. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.617 · Cited by 987
Matzinger, P. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0143 · Cited by 748
Stimulation of Human γδ T Cells by Nonpeptidic Mycobacterial Ligands
Constant, P., Davodeau, F., Peyrat, M.-A., Poquet, Y., Puzo, G., Bonneville, M., & Fournié, J.-J. (1994) · Science · doi:10.1126/science.8146660 · Cited by 711
Adjuvants—a classification and review of their modes of action
Cox, J. C., & Coulter, A. R. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00183-1 · Cited by 682
Constant, S., Pfeiffer, C., Woodard, A., Pasqualini, T., & Bottomly, K. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1591 · Cited by 677
Macrophages ingest and are activated by bacterial DNA
Stacey, K. J., Sweet, M. J., & Hume, D. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2116 · Cited by 570
Liew, F. Y., Li, Y., & Millott, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4306 · Cited by 522 · cited 1×
“Protective immunity depends on the induction of T cells producing Th1 cytokines which activate macrophages to kill the intracellular organisms primarily through a nitric oxide-mediated mechanism (74).”
BackgroundHeinzel, F. P., Sadick, M. D., Mutha, S. S., & Locksley, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7011 · Cited by 517
Th1 and Th2 subsets: paradigms lost?
Kelso, A. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80004-2 · Cited by 472
CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection
Moody, D. B., Ulrichs, T., Mühlecker, W., Young, D. C., Gurcha, S. S., Grant, E., Rosat, J.-P., Brenner, M. B., Costello, C. E., Besra, G. S., et al. (2000) · Nature · doi:10.1038/35009119 · Cited by 456
Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Röcken, M., Wagner, H., & Heeg, K. M. (1998) · PubMed · Cited by 455
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
Messina, J. P., Gilkeson, G. S., & Pisetsky, D. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.6.1759 · Cited by 371
Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Röcken, M., Wagner, H., & Heeg, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3627 · Cited by 367
Gurunathan, S., Sacks, D. L., Brown, D. R., Reiner, S. L., Charest, H., Glaichenhaus, N., & Seder, R. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1137 · Cited by 360
Expression Cloning of a Protective Leishmania Antigen
Mougneau, E., Altare, F., Wakil, A. E., Zheng, S., Coppola, T., Wang, Z.-E., Waldmann, R., Locksley, R. M., & Glaichenhaus, N. (1995) · Science · doi:10.1126/science.7725103 · Cited by 345
Hoskins, T. W., Davies, J., Smith, A. J., Miller, C., & Allchin, A. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90468-9 · Cited by 342
Immunological concepts of vaccine adjuvant activity
Schijns, V. E. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00120-5 · Cited by 330
DNA vaccines: a key for inducing long-term cellular immunity
Gurunathan, S., Wu, C.-Y., Freidag, B. L., & Seder, R. A. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00118-7 · Cited by 261
Resistance to Leishmania major Induced by Tolerance to a Single Antigen
Julia, V., Rassoulzadegan, M., & Glaichenhaus, N. (1996) · Science · doi:10.1126/science.274.5286.421 · Cited by 259
An analysis of T cell responsiveness in Indian kala-azar.
Sacks, D. L., Lal, S. L., Shrivastava, S. N., Blackwell, J., & Neva, F. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.908 · Cited by 251
Exposing the immunology of naked DNA vaccines
Pardoll, D. M., & Beckerleg, A. M. (1995) · Immunity · doi:10.1016/1074-7613(95)90085-3 · Cited by 249
Pfeffer, K., Schoel, B., Gulle, H., Kaufmann, S. H. E., & Wagner, H. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200534 · Cited by 241
Alexander, J., Coombs, G. H., & Mottram, J. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6794 · Cited by 234
Russell, D. G., & Alexander, J. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.4.1274 · Cited by 232
Development of a safe live Leishmania vaccine line by gene replacement.
Titus, R. G., Gueiros-Filho, F. J., de Freitas, L. A., & Beverley, S. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10267 · Cited by 228
Walker, P. S., Scharton-Kersten, T., Krieg, A. M., Love-Homan, L., Rowton, E. D., Udey, M. C., & Vogel, J. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6970 · Cited by 222
Immunization of non-human primates with DNA vaccines
Liu, M. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00280-0 · Cited by 215
The Host Response to Leishmania Infection
Solbach, W., & Laskay, T. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60912-8 · Cited by 204
Yamamoto, S., Kuramoto, E., Shimada, S., & Tokunaga, T. (1988) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1988.tb00049.x · Cited by 204
Crystal, R. G. (1997) · Nature Medicine · doi:10.1038/nm0497-383 · Cited by 204
Cytokines: Principles and prospects
Kelso, A. (1998) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.1998.00757.x · Cited by 187
McConville, M. J., Bacic, A., Mitchell, G. F., & Handman, E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.8941 · Cited by 179
Self-citationOrgan-specific immune responses associated with infectious disease
Engwerda, C. R., & Kaye, P. M. (2000) · Immunology Today · doi:10.1016/s0167-5699(99)01549-2 · Cited by 175
LeIF: A Recombinant Leishmania Protein That Induces an IL-12-Mediated Th1 Cytokine Profile
Skeiky, Y. A. W., Kennedy, M. K., Kaufman, D., Borges, M. M., Guderian, J. A., Scholler, J., Ovendale, P. J., Picha, K. S., Morrissey, P., Grabstein, K. H., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6171 · Cited by 170
The Multiplex Function of Nitric Oxide in (Auto)immunity
Bogdan, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1361 · Cited by 170
Genetic susceptibility to leishmanial infections: studies in mice and man
Blackwell, J. M. (1996) · Parasitology · doi:10.1017/s0031182000076678 · Cited by 167
Genetic control of natural resistance to Leishmania donovani
BRADLEY, D. J. (1974) · Nature · doi:10.1038/250353a0 · Cited by 162
Ulmer, J. B., SADOFF, J. C., & Liu, M. A. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80042-2 · Cited by 148
Immunostimulatory DNA as an Adjuvant in Vaccination againstLeishmania major
Stacey, K. J., & Blackwell, J. M. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.3719-3726.1999 · Cited by 142
Pinelli, E., Gonzalo, R., Boog, C. J. P., Rutten, V. P. M. G., Gebhard, D. H., del Real, G., & Ruitenberg, E. J. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250619 · Cited by 139
DNA Vaccines: Technology and Application as Anti-parasite and Anti-microbial Agents
Alarcon, J. B., Waine, G. J., & McManus, D. P. (1999) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(08)60152-9 · Cited by 133
Animal Parasite Control Utilizing Biotechnology
Yong, W. K. (2024) · CRC Press eBooks · doi:10.1201/9781003574880 · Cited by 131
Ahuja, S. S., Reddick, R. L., Sato, N., Montalbo, E., Kostecki, V., Zhao, W., Dolan, M. J., Melby, P. C., & Ahuja, S. K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3890 · Cited by 129
Experimental models for leishmaniasis and for testing anti-leishmanial vaccines
Hommel, M., Jaffe, C. L., Travi, B. L., & Milon, G. (1995) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1995.11813015 · Cited by 125
Sjölander, A., Baldwin, T. M., Curtis, J., & Handman, E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3949 · Cited by 122
Self-citationLeishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis
Soong, L., Duboise, S. M., Kima, P. E., & McMahon‐Pratt, D. (1995) · Infection and Immunity · doi:10.1128/iai.63.9.3559-3566.1995 · Cited by 118
Walker, P., Scharton‐Kersten, T., ROWTON, E. D., Hengge, U. R., Bouloc, A., Udey, M. C., & Vogel, J. C. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.13-1899 · Cited by 109
Handman, E., Symons, F. M., Baldwin, T. M., Curtis, J., & Scheerlinck, J. Y. (1995) · Infection and Immunity · doi:10.1128/iai.63.11.4261-4267.1995 · Cited by 109
Self-citationBlackwell, J. M., Barton, C. H., White, J. K., Roach, T. I. A., Shaw, M., Whitehead, S. H., Mock, B. A., Searle, S., Williams, H. P., & Baker, A.-M. (1994) · Immunology Letters · doi:10.1016/0165-2478(94)00161-8 · Cited by 98
Blackwell, J. M. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88773-9 · Cited by 97
Morris, L., Troutt, A. B., Handman, E., & Kelso, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.8.2715 · Cited by 96
Self-citationAbdelhak, S., Louzir, H., Timm, J., Blel, L., Benlasfar, Z., Lagranderie, M., Gheorghiu, M., Dellagi, K., & Gicquel, B. (1995) · Microbiology · doi:10.1099/13500872-141-7-1585 · Cited by 93
Sjölander, A., Baldwin, T. M., Curtis, J., Bengtsson, K. L., & Handman, E. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00075-9 · Cited by 93
Self-citationNucleic acid immunization: concepts and techniques associated with third generation vaccines
Hasan, U. A., Abai, A. M., Harper, D. R., Wren, B. W., & Morrow, W. J. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00104-0 · Cited by 92
Multidrug resistance and P-glycoproteins in parasitic protozoa
Ullman, B. (1995) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf02110334 · Cited by 92
Effect of Human Immunodeficiency Virus Type 1 Infection upon Acute Salpingitis: A Laparoscopic Study
Cohen, C. R., Sinei, S. K., Reilly, M., Bukusi, E. A., Eschenbach, D. A., Holmes, K. K., Ndinya‐Achola, J. O., Bwayo, J., Grieco, V. S., Stamm, W. E., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/314465 · Cited by 90
Sieling, P. A., Ochoa, M. T., Jullien, D., Leslie, D. S., Sabet, S., Rosat, J., Burdick, A. E., Rea, T. H., Brenner, M. B., Porcelli, S. A., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4790 · Cited by 89
Control of Leishmania major Infection in Mice Lacking TNF Receptors
Nashleanas, M., Kanaly, S. T., & Scott, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5506 · Cited by 87
Human T cell responses to gp63, a surface antigen of Leishmania
Russo, D. M., Burns, J. M., Carvalho, E. M., Armitage, R. J., Grabstein, K. H., Button, L. L., McMaster, W. R., & Reed, S. G. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.10.3575 · Cited by 83
Xu, D., McSorley, S. J., Tetley, L., Chatfield, S. N., Dougan, G., Chan, W. L., Satoskar, A. R., David, J. R., & Liew, F. Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1285 · Cited by 80
Xu, D.-Z., McSorley, S. J., Tetley, L., et al. (1998) · PubMed · Cited by 78
Morris, L., Troutt, A. B., McLeod, K. S., Kelso, A., Handman, E., & Aebischer, T. (1993) · Infection and Immunity · doi:10.1128/iai.61.8.3459-3465.1993 · Cited by 74
Self-citationScience, medicine, and the future: Leishmaniasis
Roberts, L. J. (2000) · BMJ · doi:10.1136/bmj.321.7264.801 · Cited by 67
DNA Vaccines — Designer Vaccines for the 21st Century
Seder, R. A., & Gurunathan, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410410 · Cited by 64
BCG Expressing LCR1 of Leishmania chagasi Induces Protective Immunity in Susceptible Mice
Streit, J. A., Recker, T. J., Donelson, J. E., & Wilson, M. E. (2000) · Experimental Parasitology · doi:10.1006/expr.1999.4459 · Cited by 64
Endotoxins in the blood and cerebrospinal fluid of patients with African sleeping sickness
Pentreath, V. W., Alafiatayo, R., Crawley, B. A., Doua, F., & Oppenheim, E. A. (1996) · Parasitology · doi:10.1017/s0031182000065082 · Cited by 63
Toward the development of DNA vaccines
Ulmer, J. B. (1996) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(96)80078-4 · Cited by 62
Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens
Zeng, W. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00346-1 · Cited by 57
Ahuja, S. S., Mummidi, S., Malech, H. L., & Ahuja, S. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.868 · Cited by 54
McMahon‐Pratt, D., Traub-Csekö, Y. M., Lohman, K. L., Rogers, D. D., & Beverley, S. M. (1992) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(92)90252-f · Cited by 53
Jaffe, C. L., Perez, M. L., & Schnur, L. F. (1990) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(90)90186-p · Cited by 52
Alexander, J. K. (1982) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(82)90232-2 · Cited by 51
Antigen Presentation by Macrophages Harboring Intravesicular Pathogens
Overath, P., & Aebischer, T. (1999) · Parasitology Today · doi:10.1016/s0169-4758(99)01473-8 · Cited by 48
CD1—A New Paradigm for Antigen Presentation and T Cell Activation
Sugita, M., Moody, D. B., Jackman, R. M., Grant, E. P., Rosat, J., Behar, S. M., Peters, P. J., Porcelli, S. A., & Brenner, M. B. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4500 · Cited by 44
Restrictions on the use of antigenic peptides by the immune system.
Howard, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3777 · Cited by 28
Fitzmaurice, C. J., Brown, L. E., Kronin, V. V., & Jackson, D. C. (2000) · International Immunology · doi:10.1093/intimm/12.4.527 · Cited by 28
Progress in the Leishmania genome project
Blackwell, J. M. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90187-5 · Cited by 21
Strategies for immune intervention in visceral leishmaniasis
Kaye, P. M., Gorak, P. M. A., Murphy, M., & Ross, S. A. (1995) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1995.11813016 · Cited by 18
Naked antigen-presenting molecules on dendritic cells
Davoust, J. M., & Banchereau, J. (2000) · Nature Cell Biology · doi:10.1038/35004075 · Cited by 17
Function and regulation of memory CD4 T cells
Metz, D. P., & Bottomly, K. (1999) · Immunologic Research · doi:10.1007/bf02786482 · Cited by 15
A reverse genetics approach to Bcg/Ity/Lsh gene cloning
Gros, P., & Malo, D. (1989) · Research in Immunology · doi:10.1016/0923-2494(89)90031-x · Cited by 10
Cited by
Murray, H. W., Berman, J. D., Davies, C. R., & Saravia, N. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67629-5 · Cited by 1,771
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
Chappuis, F., Sundar, S., Hailu, A., Ghalib, H., Rijal, S., Peeling, R. W., Alvar, J., & Boelaert, M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1748 · Cited by 1,490
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.174 · Cited by 891
Global Change and Human Vulnerability to Vector-Borne Diseases
Sutherst, R. W. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.136-173.2004 · Cited by 713
Canine leishmaniasis: epidemiological risk and the experimental model
Moreno, J., & Alvar, J. (2002) · Trends in Parasitology · doi:10.1016/s1471-4922(02)02347-4 · Cited by 504
Metadata
- Authors
- Handman, E.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2001-04
- Volume
- 14
- Issue
- 2
- Pages
- 229-243
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2141360780
- Cited by
- 600
- References
- 83
- FWCI
- 26.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.